- Home
- LU vs PRGO Comparison
LU vs PRGO Comparison
Compare LU & PRGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LU | PRGO |
|---|---|---|
| Founded | 2005 | 1887 |
| Country | China | Ireland |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.8B |
| IPO Year | 2020 | 2013 |
Fundamental Metrics
Financial Performance| Metric | LU | PRGO |
|---|---|---|
| Price | $1.54 | $13.02 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 3 |
| Target Price | $2.00 | ★ $19.33 |
| AVG Volume (30 Days) | 851.9K | ★ 2.9M |
| Earning Date | 05-12-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 10.28% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $800,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $22.52 | $1.02 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.20 | $9.23 |
| 52 Week High | $4.57 | $24.61 |
Technical Indicators
Market Signals| Indicator | LU | PRGO |
|---|---|---|
| Relative Strength Index (RSI) | 55.46 | 65.95 |
| Support Level | $1.44 | $12.45 |
| Resistance Level | $1.64 | $13.89 |
| Average True Range (ATR) | 0.09 | 0.52 |
| MACD | -0.00 | 0.14 |
| Stochastic Oscillator | 40.32 | 83.56 |
Price Performance
Historical ComparisonAbout LU Lufax Holding Ltd each representing two (2)
Lufax Holding Ltd is an investment holding company, together with its consolidated subsidiaries, engaged in core retail credit and enablement business to both borrowers and institutions in the People's Republic of China. The group's segments are Lending-related business, which provides Retail credit and enablement, consumer finance loans, and Digital banking business, including Retail banking and SME banking.
About PRGO Perrigo Company plc
Perrigo is a pure-play consumer healthcare product manufacturer and distributor. In North America (two-thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. It plays in a number of over-the-counter categories including pain, skincare, women's health, and nutrition. Perrigo also competes in Europe, Australia, and parts of Asia, where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.